Insulet misses first-quarter profit estimates as marketing costs weigh
(Reuters) - Insulet Corp reported first-quarter profit that missed market expectations on Thursday, weighed by higher marketing expenses, sending shares of the medical device maker down 3.7% in extended trading. The company's quarterly selling, gen...
May 09, 2024
US to post influenza A wastewater data online to assist bird flu probe, official says
By Julie Steenhuysen CHICAGO (Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) is planning to post data on influenza A found in wastewater in a public dashboard possibly as soon as Friday that could offer new clues into the outbreak...
May 09, 2024
Masimo prepared to provide one board seat if activist Politan drops proxy contest
(Reuters) -Masimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee and drops its proxy contest. Quentin Koffey-owned P...
May 09, 2024
NYC sued for denying gay employees in vitro fertilization coverage
By Daniel Wiessner (Reuters) - New York City was hit with a lawsuit on Thursday claiming it discriminates against gay male city employees by only covering the costs of in vitro fertilization for women and heterosexual couples. The proposed class ac...
May 09, 2024
Drugmaker Abbott India posts Q4 profit rise on higher sales
BENGALURU (Reuters) - Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government pricing caps on certain medicines. The company, which makes the popular antacid medicine...
May 09, 2024
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
(Reuters) - Drugmaker Viatris narrowly missed first-quarter revenue estimates on Thursday, hurt by weak sales for its older drugs such as cholesterol medication Lipitor and Norvasc for high blood pressure. Net sales in its branded drugs unit, which...
May 09, 2024
Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies
(Reuters) - Metaphore Biotechnologies said on Thursday it would collaborate with Novo Nordisk to develop up to two therapies for obesity management. (Reporting by Puyaan Singh in Benagluru; Editing by Anil D'Silva)
May 09, 2024
Merck treatment for a type of uterus cancer fails trial
(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main goal of disease-free survival in a late-stage trial. (Reporting by Christy Santhosh in Bengaluru; Editing by Shounak Dasgupta)
May 09, 2024
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
TOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as the company focused on rebuilding its drug pipeline to make up for the loss of patent protection for major sellers. Operating profit was 214.1 bill...
May 09, 2024
UK refuses to sign global vaccine treaty, The Telegraph reports
(Reuters) - Britain is refusing to sign the World Health Organization's pandemic accord because the country says it would have to give away a fifth of its vaccines, the Telegraph reported on Wednesday. Britain will only agree to a legally binding g...
May 08, 2024
Ascension warns of suspected cyberattack; clinical operations disrupted
(Reuters) - Hospital operator Ascension reported disruptions to its clinical operations on Wednesday due to a suspected cybersecurity incident and advised business partners to temporarily disconnect from its systems. Earlier this year, UnitedHealth...
May 08, 2024
US FDA recommends healthcare providers switch from Getinge's heart devices
(Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's heart devices as they continued to have safety and quality concerns. (Reporting by Sriparna Roy in Bengaluru; Edit...
May 08, 2024
Google DeepMind unveils next generation of drug discovery AI model
By Martin Coulter LONDON (Reuters) - Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the company made a si...
May 08, 2024
Teva Pharm Q1 profit misses estimates, revenue risea
By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its branded drugs to treat migrai...
May 08, 2024
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. The agreements cover cases in U.S. st...
May 08, 2024
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
(Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus. Monthly medication subscription to th...
May 08, 2024
Thai PM says cannabis to be re-listed as narcotic by end of 2024
BANGKOK (Reuters) - Thai Prime Minister Srettha Thavisin said on Wednesday that cannabis would be re-listed as a narcotic by end of 2024, in a stunning U-turn for the country two years after it became the first in the region to decriminalise its re...
May 08, 2024
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their injectable form of a schizophrenia drug had met its main goal in a late-stage study. TEV-'749, an under-the-skin version of a generic antipsychotic drug c...
May 08, 2024
Europe in whooping cough epidemic as cases soar, says health agency
LONDON (Reuters) - Countries across Europe reported a huge rise in whooping cough cases in 2023 and the first three months of 2024, with ten times as many identified as in each of the previous two years. In total, there were nearly 60,000 cases rep...
May 08, 2024
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment. The drug distributor's pharm...
May 07, 2024
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
(Reuters) - Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in China. The supplier of laboratory apparatus and instruments fo...
May 07, 2024
Pfizer reports patient death in Duchenne gene therapy study
(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's experimental gene therapy for a muscle-wasting disorder called Duchenne muscular dystrophy (DMD), the drugmaker told Reuters on Tuesday. "A fatal serious...
May 07, 2024
Idaho will seek to revive 'abortion trafficking' law in US appeals court
By Brendan Pierson (Reuters) - Idaho will urge a federal appeals court on Tuesday to revive a 2023 law making it a crime to help a minor cross state lines for an abortion without her parent's consent, which a judge blocked in November. A three-judg...
May 07, 2024
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports
(Reuters) - Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid vaccine worldwide, The Telegraph reported on Tuesday. The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday, the report added. (Reportin...
May 07, 2024
Bankrupt Steward Health puts its hospitals up for sale, discloses $9 billion in debt
By Dietrich Knauth NEW YORK (Reuters) - Bankrupt Steward Health Care has put all of its 31 U.S. hospitals up for sale, hoping to finalize transactions by the end of the summer to address its $9 billion in total liabilities, its attorneys said at a ...
May 07, 2024